References

References

1. Roberts MM, Elton RA, Robinson SE et al. Consultations for breast disease in general practice and hospital referral patterns. Br J Surg 1987; 74:1020-1022.
   
2. Cochrane RA, Singhal H, Monypenny IJ et al. Evaluation of general practitioner referrals to a specialist breast clinic according to the UK national guidelines. Eur J Surg Oncol 1997; 23:198-201.
   
3. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): A new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987; 2:1316-1319.
   
4. Minton JP, Foecking MK, Webster DJ et al. Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease. Am J Obstet Gynecol 1979; 135:157-158.
   
5. Boyd NF, McGuire V, Shannon P et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2:128-32.
   
6. Horrobin DF. The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible noneicosanoid mechanisms. Prostaglandins Leuko Essent Fatty Acids 1993; 48:101-104.
   
7. Gateley CA, Miers M, Mansel RE et al. Drug treatments for mastalgia: 17 year experience in the Cardiff mastalgia clinic. J R Soc Med 1992; 85:12-15.
   
8. Chamners GC, Asch RH, Paurstein CJ. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol 1980; 136:426-429.
   
9. Hinton CP, Bishop HN, Holliday HW et al. Double blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 1986; 40:326-330.
   
10. O'Brien PMS, Abukhalil IEH. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1990; 180:18-23.
    
11. Fentiman IS, Caleffi M, Brame K et al. Double-blind, controlled trial of tamoxifen therapy for mastalgia. Lancet 1986; 1:287-288.
    
12. Konstostolis E, Stefanidis K, Navrozoglou I et al. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 1997; 11:393-397.
    
13. Clayton RN. Gonadotrophin releasing hormone from physiology to pharmacology. Clin Endocrinol 1987; 26:361-384.
    
14. Mansel RE, Dogliotti L. A European multi-center trial of bromocriptine in cyclical mastalgia. Lancet 1990; 335:190-193.
    
15. Pasqualini JR, Cortes-Prieto J, Chetrite G et al. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int J Cancer 1997; 70:639-643.
    
16. Noguchi S, Yokouchi H, Aihara T et al. Progression of fibroadenoma to phyllodes tumour demonstrated by clonal analysis. Cancer 1995; 76:1779-1785.
    
17. Cant PJ, Madden MV, Coleman MG et al. Nonoperative management of breast masses diagnosed as fibroadenoma. Br J Surg 1995; 82: 792-794.
    
18. DuPont WD, Page DL, Parl FF et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994; 331:10-15.
    
19. Heywang-Kobrunner SH, Schreer I, Dershaw DD. Diagnostic Breast Imaging: Mammography, sonography, magnetic resonance imaging and interventional procedures. Stuttgart; New York: Thieme, 1997; 169.
    
20. Tohno E, Cosgrove DO, Sloane JP. Ultrasound Diagnosis of Breast Diseases. New York: Churchill Livingstone, 1994; 78-88.
    
21. Zurrida S, Bartoli C, Galimberti V et al. Which therapy for the unexpected phyllodes tumour of the breast? Eur J Cancer 1992; 28:654-657.
    
22. Bruzzi P, Dogliotti L, Naldoni et al. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. BMJ 1997; 314:925-928.
    
23. Dixon JM. Breast cancer risk with cyst type in cystic disease of the breast. BMJ 1997; 315:545-546.
    
24. Murad T, Contesso G, Mouriessa H. Nipple discharge from the breast. Ann Surg 1982; 195:259-264.
    
25. Dixon JM. Periductal mastitis/duct ectasia. World J Surg 1989; 13:715-20.
    
26. Carter D. Intraductal papillary tumors of the breast. Cancer 1977; 39:1689-1692.
    
27. Andersen JA, Gram JB. Radial scar in the female breast: A long-term follow-up study of 32 cases. Cancer 1984; 53:2557-2560.
    
28. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146-151.
    
29. Jensen RA, Page DL, Dupont WD et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989; 64:1977-1983.
    
30. Dupont WD, Parl FF, Hartmann WH et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993; 71:1258 -1265.
    
31. Palli D, Del Turco MR, Simoncini R et al. Benign breast disease and breast cancer: A case-control study in a cohort in Italy. Int J Cancer 1991; 47:703-706.
    
32. London SJ, Connolly JL, Schnitt SJ et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267:941-944.
    
33. Braunstein GD. Gynecomastia. N Engl J Med 1993; 328:490-495.
    
34. Parker LN, Gray DR, Lai MK et al. Treatment of gynecomastia with tamoxifen: A double-blind crossover study. Metabolism 1986; 35:705-708.
    
35. McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 1990; 83:1283-1285.